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Abstract:  Dendritic cells (DC) are major players in both innate and adaptive immune 
responses against influenza virus. These immune responses, as well as the important 
interface between the innate and adaptive systems, are orchestrated by specialized subsets of 
DC, including conventional steady-state DC, migratory DC and plasmacytoid DC. The 
characteristics and efficacy of the responses are dependent on the relative activity of these 
DC subsets, rendering DC crucial for the development of both naïve and memory immune 
responses. However, due to their critical role, DC also contribute to the immunopathological 
processes observed during acute influenza, such as that caused by the pathogenic H5N1 
viruses. Therein, the role of different DC subsets in the induction of interferon type I, pro-
inflammatory cytokine and chemokine responses is important for the outcome of interaction 
between the virus and host immune defences. The present review will present current 
knowledge on this area, relating to the importance of DC activity for the induction of 
efficacious humoral and cell-mediated immune responses. This will include the main viral 
elements associated with the triggering or inhibition of DC activation. Finally, the current 
knowledge on understanding how differences in various vaccines influence the manner of 
immune defence induction will be presented. 
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1. Introduction 
During the last 25 years, influenza A virus (IAV) has served as an important model to understand 
and dissect the essential roles played by dendritic cells (DC) in immunity against virus infections. This 
applies to both innate immune responses – including interferon (IFN) type I, other cytokine, and 
chemokine secretion – and the development of adaptive immune defences – including CD4 helper  
T-cell (Th), CD8 cytotoxic T-cell (Tc) and antibody responses. Here we review the current knowledge 
in these areas, and highlight the value for translational research towards improving human vaccines 
against influenza as well as the important gaps in this knowledge.  
2. Innate immunity 
2.1. Importance of DC responses in innate immunity 
IAV has been extensively described as a model virus to study DC involvement in innate immune 
responses. Effective innate immune responses are important in terms of the variety of defence 
functions mediated: (i) Limiting early virus replication prior to adaptive immune defence development, 
particularly through secretion of cytokines with antiviral activity, such as type I IFN (ii) recruiting by 
DC-derived chemokine activities of inflammatory cells and additional DC to the sites of infection, 
which enhance the innate responses including phagocytosis of apoptotic and necrotic cells containing 
virus; (iii) release of IFN and other cytokines, which in turn provide alarm signals to the immune 
system for activating cells of both the innate and adaptive systems, such as NK cells and cytotoxic  
T cells. In addition to the innate defence activities, DC are also involved in promoting adaptive 
responses, for which the elements (ii) and (iii) above are particularly essential. Indeed, it is this dual 
function of DC in mediating innate responses and acting as professional antigen presenting cells that 
provides the linking of innate and adaptive immune responses. These general aspects of DC biology 
have been reviewed more extensively by others [1-3]. The present section will focus primarily on the 
innate defences, with the adaptive immunity being considered later in the review. 
IAV models (together with other viral models) have demonstrated that DC represent an important 
family of cells promoting antiviral innate immunity. Therein, an important contributory element is the 
specialized expression of receptors designed to respond to alterations in the environment with the cells 
have contact. Particularly important are the Toll like receptors (TLR) such as TLR3, TLR7, TLR8 and 
TLR9 involved in sensing viruses [4]. In this context, one realizes the significance of the two main 
functional specialized DC subsets – the so-called conventional DC (cDC) and plasmacytoid DC 
(pDC). The existence of these subsets appears to be widely conserved and a fundamental element in 
mammalian DC biology and response against viruses [5,6]. While the so-called cDC represent what 
can be termed classical DC with respect to their main function being antigen presentation, the pDC are 
distinctive in terms of their main function being as professional IFN type I-producing cells, with a 
particular ability to sense viruses [5]. This functional specialization of pDC relates to their constitutive 
expression of high levels of TLR7 and TLR9 as well as of IRF7, the most potent transcription factor 
for IFN type I production [7]. Furthermore, pDC possess important endocytic properties such as the 
ability to retain RNA and DNA in the TLR-containing endosomes, which permits a better interaction 
of the viral nucleic acid with the TLR and the signalling molecules Myd88 and IRF-7 [8]. In contrast, Viruses 2009, 1                                       
 
 
1024
cDC respond to IAV in a TLR-independent manner [9], and sense influenza virus primarily via the 
helicase retinoic acid inducible gene I (RIG-I), representing a cytosolic RNA receptor [10]. 
2.2. DC responses to influenza A viruses 
IAV can infect DC, leading to the synthesis of viral proteins. The infection is usually abortive in 
terms of infectious progeny generation, and non-cytopathogenic [11], although H5N1 viruses have 
been described to replicate in human and mouse DC yielding a cytopathic effect [12,13]. Often, IAV 
infection of both cDC and pDC activates the cells, and the maturation process is induced. This is seen 
in terms of co-stimulatory and MHC molecule upregulation, as well as CCR7 synthesis, a key 
chemokine receptor for DC migration to lymphoid tissue [11,14]. Nevertheless, as seen with the 
overview of this topic in Table 1, the degree of activation and the type of response induced is very 
much dependent on the IAV strain selected, the species under study, the exact subset of DC analyzed. 
Moreover, the type of virus preparation (e.g. purified, egg- or cell-derived) will have a strong 
influence, as will the treatment of the virus preparation (e.g. live, UV-, chemically or heat inactivated). 
Finally, the dose of virus applied to the DC is also critical with respect to the outcome of that 
interaction. Consequently, it is not surprising to find that results in the literature can present apparently 
conflicting conclusions.  
2.3. Relative roles of different DC subsets responding to influenza A viruses 
As with many (or even all viruses), IAV has the capacity to counter innate immune responses in its 
primary target cells, represented by epithelial cells. A main element therein is preventing the induction 
and action of type I IFN, effected primarily through the functions of the viral non-structural protein 
NS1 (for recent reviews see [15,16]). This type of inhibition is also active in IAV-infected cDC. In 
contrast, pDC are strongly activated by IAV despite the presence of NS1, resulting in induction of 
inflammatory and IFN responses (Table 1). Considering that pDC are an important source of not only 
IFN type I, but also proinflammatory cytokines and chemokines [17] (Table 1), it could be proposed 
that pDC assure innate immune responses, certainly against influenza viruses. Stimulation of pDC 
requires IAV binding to sialic acid receptors and an intact endocytic system (unpublished results, 
[18]). Whether fusiogenic activity is required remains unclear, but denaturation of the virus by heat 
treatment (>60°C) destroys its interferogenic properties (own unpublished results using porcine pDC). 
Studies with mouse pDC have demonstrated that the actual activation of the pDC likely occurs through 
TLR7-mediated recognition of single-stranded RNA [19], and is independent of virus replication [20]. 
In support of this concept, it has been shown that influenza virus-derived virosomes cannot activate 
pDC (own unpublished results, [21,22].  
Murine studies have indicated that pDC provide a major contribution to IFN type I responses during 
influenza [23]. In particular, pDC would contribute to early IFN responses in lymphoid tissue as a 
consequence of their presence in these organs, as well as their constitutive expression of IRF7 [24]. 
This IFN can also promote a positive feedback in the respiratory tract in terms of IRF7 induction, thus 
licensing non-pDC including cDC and epithelial cells for IFN type I production [24-26]. On the other 
hand, in vivo studies with mice have demonstrated that the respiratory epithelium also represents an 
important source of IFN type I [23]. These studies relate to two recent reports performed in mice Viruses 2009, 1                                       
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suggesting that pDC are dispensable for protective immunity against influenza [27,28]. However, it is 
uncertain whether this will also apply to natural hosts of IAV such as man and pig. One reason to 
doubt this is that the laboratory strains used for the above studies have a defective Mx gene. The Mx 
system represents an important response mechanism to type I IFN-dependent signalling, and confers 
protection to mice against IAV infection [29]. In fact, Mx-competent mice are even resistant to the 
1918 H1N1 and highly pathogenic H5N1 viruses [30]. It could thus be speculated that in   
Mx-compentent mice the pDC-derived IFN could have an important contribution to protective antiviral 
innate immune responses.  
In contrast to pDC, cDC respond only to live IAV , and this leads to a classical profile of DC 
maturation, together with the release of proinflammatory cytokines and chemokines (Table 1; for 
example [14,18,31]). The release of chemokines from infected human DC occurs in three waves 
following an apparent program to recruit effector cells of the innate immune response, followed by 
effector memory cells and naïve B and T cells [17]. It is important to note that the influenza virus NS1 
protein can also downregulate this cDC activation and maturation. Wild-type IAV infection of cDC 
induces only a relatively modest cytokine production. In contrast, NS1 deletion mutants (NS1) are 
potent activators of both mouse and human cDC, promoting DC maturation and induction of IFN, 
other cytokines and chemokine responses [32,33]. Due to these characteristics, NS1 viruses have 
been proposed as promising candidates for a live vaccine [34,35]. 
Table 1. Innate immune responses involving DC induced by IAV. 
 
IFN-   Pro-inflammatory  
cytokines 
chemokines maturation
b 
 pDC  cDC  pDC  cDC  pDC  cDC  pDC  cDC 
Live virus  ++++  -/+
a IL-6,   
TNF-,  
IL-12 
IL-6
a,  
TNF-
 a, 
IL-12
a  
 
CCL3, 4, 22 
CXCL10, 11, 13 
CCL2, 4, 5, 8, 19, 
22 
CXCL9, 10, 11, 13
a 
+ + 
NS1 
mutant 
? ++  ?  High   
responses 
? High  responses 
 
+ ++ 
Inactivated 
virus
c 
++++ -  As  live 
virus 
-/+
d  
 
? ?  +  - 
a low or undectable, potently increased after IFN- priming 
b measured in terms of MHC II, CD40, CD83, CD86 and CCR7 upregulation (dependent on the particular study) 
c requires intact HA and fusiogenic activity 
d conflicting reports 
3. Adaptive immunity 
3.1. Importance of DC for induction of CD4 and CD8 responses 
It is well established that DC play a major role as professional antigen presenting cells for priming 
of both CD4 Th and CD8 Tc lymphocytes [36]. For Th responses any protein antigen will be taken up 
by DC and at least in part be degraded in the endosomal pathway resulting in presentation through 
MHC class II. A critical issue of this presentation is the activation of DC which will promote antigen 
degradation and stable presentation of many MHC class II peptide complexes on the DC surface Viruses 2009, 1                                       
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together with costimulatory molecules such as CD80 and CD86 [36]. Adoptive transfer experiments 
have demonstrated that such CD4 Th responses can protect mice from lethal challenge infection [37]. 
This protection required B cells indicating that the classical helper function of CD4 T-cells is 
important in protection against influenza, although functional diverse subsets of CD4 Th have been 
described including some with cytotoxic activity [38]. Early in vitro studies with mouse splenic DC 
indicated that DC infected with live virus stimulated both CD4 Th and CD8 Tc, whereas those loaded 
with inactivated virus tended to induce only CD4 responses [39]. However, a later study with human 
DC demonstrated that inactivated virus with intact fusiogenic activity could restimulate Tc [40]. This 
relates to the necessity of antigenic peptide to access the MHC class I presentation machinery, which 
can be by de novo synthesis of viral proteins or by cross-presentation of endocytosed antigen. Cross-
presentation can be mediated by transfer of antigen to the cytosol, delivery to the proteosome and the 
ER. Alternatively, MHC class I molecules get access to the endosomal compartment. There are many 
pathways controlling such processes, which have been reviewed extensively elsewhere [41,42]. In 
principle, theses processes depend on the type of receptor used for endocytosis of the antigen, the 
activation state of the DC and the functional specialization of the DC subset (see below). With respect 
to conventional influenza vaccines these pathway are is still not sufficiently exploited as only live 
vaccines seem to efficiently promote influenza specific Tc responses [43]. 
3.2. Involvement of respiratory DC in promoting T-lymphocyte responses 
More recent studies performed with murine in vivo models have been focusing on the role of 
various DC subsets – summarized in Table 2. Clearly, both cDC and pDC have the ability to stimulate 
naïve CD8 T cells and cross-present antigen [14,44]. Zammit et al. [45] have even demonstrated an 
important role for cDC in restimulation of Tc memory responses in vivo. More detailed studies on 
various subsets of respiratory DC (RDC) in murine models have demonstrated a distinct functional 
specialization. Of particular importance for protective immunity against IAV are the intraepithelial DC 
present in the trachea and the conductive airways. These intraepithelial RDC, which in the mouse are 
CD11b
-CD11c
+CD103
+Langerin
+, are present under steady state conditions. Following IAV infection, 
they rapidly migrate to the draining mediastinal lymph nodes (MLNs), where antigen presentation and 
induction of adaptive immune responses occurs [27,46]. This relates to the observation that 
intraepithelial RDC are efficiently infected by IAV, both in vitro and in vivo, and thus carry antigen to 
the MLN [46,47].  
A second population of RDC in the submucosa of conducting airways are identified as 
CD11b
+CD11c
+CD103
- in mice. These cells increase significantly in number during influenza, and 
also become positive for the viral nucleoprotein [27,46,48]. However, the published reports are in 
disagreement about their actual role in antigen presentation, which may reflect the virus stains being 
employed and the use of mouse models for the analyses.  
Finally, there are various subsets of DC in the interstitium of the lung. These include pDC as well as 
resident cDC subsets. In addition, under inflammation there is a prominent increase in the number of 
monocyte-derived inflammatory DC. The latter apparently participate in inflammatory reactions, and 
promote CD8 effector T-cell recruitment and proliferation [49], although they do not seem to be 
involved in antigen presentation within the MLN [27,46]. There are several studies demonstrating that Viruses 2009, 1                                       
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the resident MLN DC present IAV antigen, promoting CD8 T-cell responses (in the mouse, these are 
defined as the CD8+ DC subset) [50,51]. It has been proposed that this is at least in part mediated by 
antigen derived from migrating RDC, in particular the intraepithelial RDC subset [52,53]. While 
preparing this manuscript another review giving more detail on RDC was published [54].  
Table 2. Adaptive effector immune responses mediated by DC
a. 
 CD8
+ Tc lymphocytes  Antibody 
Intraepithelial RDC
b  Potent priming  No evidence for a direct role 
Steady-state submucosal  
or interstitial RDC 
Conflicting reports  No evidence for a direct role 
Monocyte-derived  
inflammatory RDC 
Local expansion in lung  No evidence for a direct role 
pDC 
 
Conflicting reports  B-cell differentiation and 
isotype switching 
Resident steady-state  
lymph node DC 
Potent priming  No evidence for a direct role 
a based on mouse models 
b respiratory DC 
 
3.3. Involvement of pDC in promoting T-lymphocyte responses 
In addition to the above studies on the various cDC subsets, there has also been work on the role of 
pDC in promoting adaptive immune responses. Attempts to identify the contribution of pDC have 
employed antibody-based depletion studies in mice. However, they were unable to define any 
prominent role for this DC subset in CD8 T-cell priming during influenza [27]. It should be noted that 
pDC can promote the maturation of cDC necessary for efficient antigen presentation and therefore 
activation of adaptive immune responses. An absence of an apparent role for pDC in development of 
Tc responses might imply that this “cDC maturation-inducing” activity is not an absolute requirement. 
However, one has to remain cautious when interpreting results from one species as being applicable to 
other species. This is particularly the case with mice, wherein the responsiveness of cDC and pDC may 
show distinctive characteristics when compared with that observed for human and porcine cDC and 
pDC [6,55,56]. 
3.4. DC and the induction of antibody responses 
Considering the essential role played by DC in inducing antigen-specific T lymphocyte responses, it 
is evident that DC would contribute indirectly to B-lymphocyte responses through the activation of  
Th-cell responses. In contrast, there is no information concerning any direct interaction of DC with 
influenza virus-specific B-cells. Moreover, DC depletion using the CD11c-diphteria toxin receptor 
mouse model indicated no contribution of CD11c
+ DC to antibody responses [27]. This study did show 
that pDC were important, in that their depletion reduced the levels of antibody induced. Previous work 
had demonstrated that IAV-activated human pDC can promote plasma cell differentiation, in which Viruses 2009, 1                                       
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pDC production of IL6 and IFN- were important [57]. This role of pDC was confirmed indirectly 
using a MyD88- and TLR7-knockout mouse model. Mice lacking these molecules, which are essential 
signalling elements for pDC activation and IFN- release, had a defective isotype switching [58]. This 
also applies to the immune response induced by a whole virus inactivated influenza vaccine but not to 
split virus or subunit vaccines in mice [59].  
4. Immunopathology 
4.1. Roles for DC in influenza virus-induced immunopathology 
Immune responses have the character of a double-edged sword, on the one side controlling immune 
defence development and homeostasis, on the other side contributing to immunopathological 
phenomena when over-activated or under loss of control. The latter is a relevant area to virus 
infections which interfere with aspects of immune defence regulation. Accordingly, it would not be 
surprising to find a role for DC in immunopathological reactions associated with IAV infections. 
Certainly, aberrant cytokine responses have been proposed as one of the triggers leading to fatal 
infections in humans with H5N1 viruses [60,61]. Such reactions are likely mediated by overproduction 
of IFN type I together with proinflammatory cytokines or other inflammatory mediators. In this 
context, one needs to consider pDC, known to be the most potent producers of   
IFN- as well as certain pro-inflammatory cytokines such as TNF- and IL-6 [5]. As described above, 
such IFN- will sensitize other cells including cDC and epithelial cells for additional IFN type I 
production, as well as release of other cytokines and chemokine [24-26].  
4.2. The “cytokine storm” phenomenon 
An excessive or imbalanced production of such cytokines and chemokines would interfere with the 
normal functioning and control of immune response developments and homeostasis, leading to 
immunopathological situations. However, it has not been possible to confirm such a role for pDC, at 
least in mouse models [27,28]. Furthermore, a general inhibition of cytokine responses in mouse 
models did not significantly alter the course of the disease [62,63]. This could question the concept of 
a role for cytokines in IAV-induced disease – the “cytokine storm” concept – but it may equally 
question the value of the mouse model for such studies. Certainly, IAV often requires adaptation to 
mice for studies in this model, or the use of particular mice strains (often with congenital defects). 
Moreover, a recent study using non-human primates has provided data supporting the “cytokine storm” 
concept [64]. H5N1 viruses are also known to be relatively more potent activators of human pDC 
compared with human IAV [65], at least in vitro. However, one should bear in mind that the “cytokine 
storm” alone is unlikely to be responsible for all aspects of IAV pathogenesis, and H5N1 fatality 
probably results from a combination of events following virus infection of the host [60]. 
4.3. Roles for DC other than the pDC 
In addition to pDC, other DC such as monocyte-derived inflammatory DC, which accumulate in the 
lung during infection, are likely to participate in disease processes. This has been demonstrated in a 
mouse model for so-called TNF/iNOS-producing DC, which are of monocyte origin [49]. Also human Viruses 2009, 1                                       
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monocyte-derived DC and blood myeloid DC are efficiently infected and even killed by H5N1 viruses 
at least in vitro [12]. This might provide indications relating to the virulence of such viruses. However, 
more work is required in this area to define the potential roles played by the different DC subsets, 
particularly those in mucosal sites of the body such as the various RDC, and also in species which are 
more natural hosts for IAV. It is likely that the different DC subsets will play particular roles during 
IAV infection and disease development. Their activities will in turn be influenced by events occurring 
in situ, including the activities of infected epithelial and endothelial cells, as well as inflammatory 
infiltrates. 
5. Conclusions and implications for vaccines 
The knowledge which has accumulated on the family of DC – their distinct anatomical localization, 
migratory properties, and specialized function in innate and adaptive immune responses – provides 
important insights to aid development of more efficacious and tailored vaccines. From mouse studies 
at least, it is evident that activation of CD4, CD8 and B-cell responses is ensured by specialized 
subsets of DC. Certainly, the triggering of innate immune responses by targeting pDC has the potential 
to promote T- and B-cell responses. This could partially explain the reports demonstrating higher 
potency for whole inactivated vaccines compared with virosomes and subunit vaccines, with respect to 
antibody induction [22,66]. One should also consider the potential value of targeting intraepithelial DC 
in the lung airways, which efficiently migrate to the draining lymph nodes for presentation of antigen 
and induction of adaptive immunity. Such targeting is important for promoting mucosal (intranasal) 
vaccination, which is currently lagging well behind in development compared with parenteral 
vaccination strategies. Studies with mouse models have indicated that cDC may not be crucial for the 
B-cell response against influenza. Of course, the open question is how this can relate to the role of 
cDC in other mammals more closely related immunologically to humans, or in which natural isolates 
of IAV can replicate and/or cause disease. If cDC are indeed less important for the direct activation of 
B-cell responses, one has to consider that a vaccine formulation should contain independent 
components targeting DC to promote effector T cell responses, as well as directly targeting B cells for 
efficient antibody responses. Both elements will be required for improved vaccines. This is an area 
necessitating elaboration if we are to promote more efficacious and better targeted vaccines against 
IAV. It is evident that translational research on the human counterparts of the different RDC, 
inflammatory migratory DC and the steady state lymph node DC is now required to identify their 
contribution in the immune response against influenza virus. With such information, one can progress 
rapidly with the possibilities of targeting these DC, and how best such targeted vaccines should be 
designed.  
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